Alkem Laboratories Limited — Results, 07-02-2025: Integrated Filing- Financial

Alkem Laboratories has announced a board meeting to review the financial results for the quarter and nine months ended 31 December 2024. The consolidated revenue from operations rose to ₹33,742.8 crore, while profit after tax registered at ₹6,407.9 crore. Notably, the company declared an interim dividend of ₹37 per equity share, highlighting a strong return to shareholders. The transfer of its Generic Business to a subsidiary is in process, with no immediate impact on consolidated figures. This positive outlook may bolster investor sentiment as the company continues to focus on operational efficiencies.